Dr. Hayley Wilson is a policy analyst in biomedical science with a background in bacterial genomics. Since being at PHG she has worked on blood based biomarkers, data management, next-generation sequencing and rare disease therapies
Hayley completed her PhD in medical microbiology at the University of Cambridge where she developed skills in whole genome sequencing and pathogen genomics, particularly looking at multi-drug-resistant bacteria and their impact upon asymptomatic patient populations.
Key skills are:
- Pathogen genomics analysis
- Epidemiological study coordination
- Computational biology research
- Multidisciplinary sector collaboration
- Science communication
- How can genomics inform the public health response to the threat of Meningococcal Disease?
- Addressing sepsis requires speedy solutions: enter rapid diagnostics
- Sepsis and superbugs: two edges of the same sword
- Hidden in plain sight: The untapped power of data for personalised health
- ctDNA:progress on streamlining cancer diagnosis
- Metagenomic sequencing in public health – can long read sequencing be used to tackle antimicrobial resistance?
- The Sudlow Review – can it succeed where others have failed?
- Future-proofing protection against pandemics
- Fragmentomics – the future of cfDNA testing?
- Personalized prevention of neurodegenerative diseases: scoping review and evidence gap map. Cristina Barahona-López, Elena Plans-Beriso et al incl. Hayley Wilson. https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70980?utm_medium=article&utm_source=researchgate.net December 2025
- Biomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review. Babb de Villiers C, Plans-Beriso E, Erady C, Blackburn L, Wilson H, Turner H, Kuhn I, Barahona-López C, Diez-Echave P, Hernández OR, et al. International Journal of Molecular Sciences. 2025; 26(19):9346.
